I am a little disappointed rs-1969, by the delay in appreciation.

Likely, Poly is in the throws of fund-raising that $12 to $20 million privately and we are temporarily stuck. When the deal is finially done we will see a 'couple of bucks' stock price quickly. Soon after this they will, for heaven's sake, announce results and they will be darn good given we haven't heard yet--VERY good sign!

After that, likely some partial funding(likely from a Pharm), because the verdict won't be in full until Phase II shows great promise and results. If they go the full trial with success then we could see a $15 to $20 price.

Right now I've adjusted my thinking to $4 to $5 until May when they get Phase II started. Then the slow climb with no sale-out unless a Pharma pays $17 in early part of trials. Really, I don't see it given the conservative valuation now, but waitng until early 2011 with better than good results will price this at $20 and maybe then some.